Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter

Virology

Volumn 252, Issue 1, 1998, Pages 149-161

  Bell, Andrew ^a   Skinner, Julia ^a   Kirby, Helen ^a   Rickinson, Alan ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CELL GROWTH; CELL TRANSFORMATION; EPSTEIN BARR VIRUS; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS CHARACTERIZATION; VIRUS EXPRESSION;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4; PROKARYOTA;

EID: 0032488238     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9440     Document Type: Article

References (51)

1. Abbot S. D., Rowe M., Cadwallader K., Gordon J., Ricksten A., Rymo L., Rickinson A. B. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-coded latent membrane protein. J. Virol. 64:1990;2126-2134.
2. Alfieri C., Birkenbach M., Kieff E. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 181:1991;595-608.
3. Altiok E., Minarovits J., Li-Fu H., Contreras-Brodin B., Klein G., Ernberg I. Host cell phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. Proc. Natl. Acad. Sci. USA. 89:1992;905-909.
4. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P. S., Barrell B. G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
5. Contreras-Brodin B., Karlsson A., Nilsson T., Rymo L., Klein G. B cell specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. J. Gen. Virol. 77:1996;1159-1162.
6. Cordier M., Calender A., Billaud M., Zimber U., Rousselet G., Pavlish O., Banchereau J., Tursz T., Bornkamm G., Lenoir G. M. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23. J. Virol. 64:1990;1002-1013.
7. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
8. Fåhraeus R., Jansson A., Ricksten A., Sjoblom A., Rymo L. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl. Acad. Sci. USA. 87:1990;7390-7394.
9. Grossman S. R., Johannsen E., Tong X., Yalamanchilli R., Kieff E. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc. Natl. Acad. Sci. USA. 91:1994;7568-7572.
10. Henkel T., Ling P. D., Hayward S. D., Peterson M. G. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein JK. Science. 265:1994;92-95.
11. Jansson A., Masucci M., Rymo L. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus W promoter in Burkitt lymphoma lines. J. Virol. 66:1992;62-69.
12. Kieff E. Epstein-Barr virus and its replication. Field's Virology. 1996;Lippincott-Raven, Philadelphia. p. 2343-2396.
13. Knox P. G., Li Q. X., Rickinson A. B., Young L. S. In vitro. Virology. 215:1996;40-50.
14. Lalli E., Sassone-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem. 269:1994;17359-17362.
15. Ling P. D., Rawlins D. R., Hayward S. D. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad. Sci. USA. 90:1993;9237-9241.
16. Meyer T. E., Habener J. F. Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription activating deoxyribonucleic acid binding proteins. Endocr. Rev. 14:1993;269-290.
17. Nemerow G. R., Mold C., Schwend V. K., Tollefson V., Cooper N. R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment. J. Virol. 61:1987;1416-1420.
18. Nilsson T., Sjoblom A., Masucci M. G., Rymo L. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Virology. 193:1993;774-785.
19. Nitsche F., Bell A., Rickinson A. Epstein-Barr virus leader protein (EBNA-LP) enhances the EBNA2-mediated transactivation of latent membrane protein LMP1 expression: A role for the W1W2 repeat domain. J. Virol. 71:1997;6619-6628.
20. Nonkwelo C., Skinner J., Bell A., Rickinson A., Sample J. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70:1996;623-627.
21. Park K., Atchison M. Isolation of a candidate repressor/activator, NF-E1 (YY1, delta) that binds to the immunoglobulin K 3′ enhancer and the immunoglobulin heavychain mu E1 site. Proc. Natl. Acad. Sci. USA. 88:1991;9804-9808.
22. Puglielli M. T., Desai N., Speck S. H. Regulation of EBNA gene transcription in lymphoblastoid cell lines: Characterisation of sequences downstream of BCR2 (Cp). J. Virol. 71:1997;120-128.
23. Puglielli M. T., Woisetschlaeger M., Speck S. H. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus immortalised lymphoblastoid cell lines. J. Virol. 70:1996;5758-5768.
24. Rickinson A. B., Kieff E. Epstein-Barr virus. Fields B. N., Knipe D. M., Howley P. M. Field's Virology. 1996;2397-2446 Lippincott-Raven, Philadelphia.
25. Ricksten A., Olsson A., Andersson T., Rymo L. The 5′ flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B cells. Nucleic Acids Res. 16:1988;8391-8410.
26. Robertson K. D., Hayward S. D., Ling P. D., Samid D., Ambinder R. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: Evidence that demethylation at a single CpG site is crucial. Mol. Cell. Biol. 15:1995;6150-6159.
27. Rooney C. M., Brimmell M., Buschle M., Allan G., Farrell P. J., Kolman J. L. Host cell and EBNA2 regulation of Epstein-Barr virus latent cycle promoter activity in B lymphocytes. J. Virol. 66:1992;496-504.
28. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
29. Sample J., Brooks L., Sample C., Young L., Rowe M., Gregory C., Rickinson A., Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA. 88:1991;6343-6347.
30. Sample J., Hummel. M., Braun D., Birkenbach M., Kieff E. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: A probable transcriptional initiation site. Proc. Natl. Acad. Sci. USA. 83:1986;5096-5100.
31. Schaefer B., Strominger J. L., Speck S. H. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA. 92:1995;10565-10569.
32. Schaefer B., Woisetschlaeger M., Strominger J. L., Speck S. H. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Natl. Acad. Sci. USA. 88:1991;6550-6554.
33. Shi Y., Seto E., Chang L., Shenk T. Transcriptional repression by YY-1, a human GLI kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 67:1991;377-388.
34. Shrivastava A., Calame K. An analysis of genes regulated by the multifunctional transcriptional regulator Yin-Yang-1. Nucleic Acids Res. 22:1994;5151-5155.
35. Sinclair A. J., Palmero I., Peters G., Farrell P. J. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:1994;3321-3328.
36. Smith P. R., Griffin B. E. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J. Virol. 66:1992;706-714.
37. Sugano N., Chen W., Roberts M. L., Cooper N. R. Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-κB activation. J. Exp. Med. 186:1997;1-7.
38. Sugden B., Warren N. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA1, a viral protein required for viral DNA replication during latent infection. J. Virol. 63:1989;2644-2649.
39. Sung N. S., Kenney S., Gutsch D., Pagano J. S. EBNA2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J. Virol. 65:1991;2164-2169.
40. Tanner J., Weis J., Fearon D., Whang Y., Kieff E. Epstein-Barr virus gp350/220 binding to B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell. 50:1987;203-213.
41. Usheva A., Shenk T. TATA-binding protein-independent initiation: YY1, TFIIB and RNA polymerase II direct basal transcription on supercoiled DNA. Cell. 76:1994;1115-1121.
42. Walls D., Perricaudet M. Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter. EMBO J. 10:1991;143-151.
43. Waltzer L., Logeat F., Brou C., Israel A., Sergeant A., Manet E. The human JK recombination signal sequence binding protein (RBP-JK) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J. 13:1994;5633-5638.
44. Wang F., Gregory C., Rowe M., Rickinson A. B., Wang D., Birkenbach M., Kikutani H., Kishimoto T., Kieff E. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B cell activation antigen CD23. Proc. Natl. Acad. Sci. USA. 84:1987;3452-3456.
45. Wang F., Tsang S.-F., Kurilla M. G., Cohen J. J., Kieff E. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 64:1990;3407-3416.
46. Wingender E., Dietze P., Karas H., Knuppel R. TRANSFAC: A database of transcription factors and their DNA binding sites. Nucleic Acids Res. 24:1996;238-241.
47. Woisetschlaeger M., Jin X. W., Yandava C. N., Furmanski L. A., Strominger J. L., Speck S. H. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during the initial stages of infection. J. Virol. 88:1991;3942-3946.
48. Woisetschlaeger M., Yandava C. N., Furmanski L. A., Strominger J. L., Speck S. H. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA. 87:1990;1725-1729.
49. Xie H., Wang Z., Rothstein T. L. Signaling pathways for antigen receptor-mediated induction of transcription factor CREB in B lymphocytes. Cell Immunol. 169:1996;264-270.
50. Zimber-Strobl Z., Strobl L. J., Meitinger C., Hinrichs R., Sakai T., Furukawa T., Honjo T., Bornkamm G. W. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through the interaction with recombination signal binding protein RBP-J kappa, the homologue ofDrosophila. EMBO J. 13:1994;4973-4982.
51. Zimber-Strobl U., Suentzenich K.-O., Laux G., Eick E., Cordier M., Calender A., Billaud M., Lenoir G. M., Bornkamm G. W. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol. 65:1991;415-423.